OMER Stock Analysis: Buy, Sell, or Hold?
OMER - Omeros Corporation
$12.56
0.72 (6.08%)
▲
5d:
+10.76%
30d:
+35.34%
90d:
-16.6%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 13, 2026
9d
Smart Money Distribution
None View Scanner →
Strength: 7.7/10
Get Alerted When OMER Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: OMER is 11.8% above its trading range ($11.23). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: OMER is 11.8% above its trading range ($11.23). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$13.31
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$8.27
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OMER is currently trading at $12.56, which is considered extended relative to its 30-day fair value range of $9.40 to $11.23. From a valuation perspective, the stock is trading at a discount (Forward PE: 33.0) compared to its historical average (77.5). Remarkably, the market is currently pricing in an annual earnings decline of 24.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, OMER is in a strong uptrend. The price is approaching resistance at $12.59. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.1% recently.
Market Sentiment: OMER has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.00 (+162.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OMER is in a strong uptrend. The price is approaching resistance at $12.59. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 6.1% recently.
Market Sentiment: OMER has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.00 (+162.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.40 -
$11.23
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding OMER? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+11.8% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.1%)
- BULLISH: Trading 162.7% below Wall St target ($33.00)
Trading Range Analysis
30-Day Trading Range
$9.40 -
$11.23
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$9.34
Resistance Level
$12.59
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
33.05
Wall Street Target
$33.00
(+162.7%)
Revenue Growth (YoY)
14.9%
Profit Margin
871.0%
Valuation Discount vs History
-24.7% cheaper
PE vs Historical
33.1 vs 77.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-24.7%
(market-implied from PE analysis)
1-Year Target
$11.30
(-10%)
2-Year Target
$10.17
(-19%)
3-Year Target
$9.16
(-27%)
3-Yr Target (if PE normalizes)
(PE: 33→78)
$21.47
(+71%)
📈
Valuation based on Current Earnings
Trailing PE: 10.39 | Current EPS (TTM): $1.14
Bull Case
$6.51
(-48%)
Analyst growth -50.0%, PE expands to 11.4
Base Case
$5.92
(-53%)
Market implied -50.0%, PE stable at 10.4
Bear Case
$8.05
(-36%)
Severe decline -20.0%, PE contracts to 8.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 33.1 to 77.5
Stabilization Target:
$29.45
(+134.5%)
PE Expansion Potential:
+134.5%
Share & Embed Analysis
Last updated: August 03, 2026 6:33 PM ET
Data refreshes hourly during market hours. Next update: 7:33 PM
Data refreshes hourly during market hours. Next update: 7:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OMER showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 53 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$386 | 43 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$557 | 49 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 54 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
Advanced OMER Option Strategies
Professional options setups generated by AI based on today's OMER price and gamma walls.
